Mesoblast (MESO) Short term Debt (2018 - 2025)
Mesoblast (MESO) posted quarterly Short term Debt of $66.7 million for Q4 2025, down 34.23% year-on-year from $101.5 million in Q4 2024, and down 1.48% on a QoQ basis from $67.7 million in Q2 2025.
Mesoblast (MESO) Short term Debt (2018 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Short term Debt for 8 consecutive years, with $66.7 million the latest figure, recorded in Q4 2025.
- Quarterly Short term Debt fell 34.23% year-over-year to $66.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $66.7 million (down 34.23% YoY) and the FY2025 annual result came in at $67.7 million, up 388.67% from the prior year.
- Short term Debt slipped to $66.7 million in Q4 2025 per MESO's latest filing, from $67.7 million in the prior quarter.
- Over the last five years, Short term Debt for MESO reached as high as $107.2 million in Q4 2023 and fell as low as $5.0 million in Q2 2022.
- A 5-year average of $67.1 million and a median of $77.1 million in 2021 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2022 — Short term Debt sank 90.57% — and 2025, when it soared 388.67%.
- Year by year, Short term Debt stood at $86.5 million in 2021, then gained by 12.07% to $97.0 million in 2022, then gained by 10.56% to $107.2 million in 2023, then decreased by 5.37% to $101.5 million in 2024, then sank by 34.23% to $66.7 million in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $66.7 million, $67.7 million, and $101.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.74 Mn |
| Jun 30, 2025 | 67.74 Mn |
| Dec 31, 2024 | 101.48 Mn |
| Jun 30, 2024 | 13.86 Mn |
| Dec 31, 2023 | 107.23 Mn |
| Jun 30, 2023 | 5.95 Mn |
| Mar 31, 2023 | 99.04 Mn |
| Dec 31, 2022 | 96.98 Mn |
| Sep 30, 2022 | 94.19 Mn |
| Jun 30, 2022 | 5.02 Mn |
| Mar 31, 2022 | 88.65 Mn |
| Dec 31, 2021 | 86.54 Mn |
| Jun 30, 2021 | 53.20 Mn |
| Mar 31, 2021 | 52.67 Mn |
| Dec 31, 2020 | 49.09 Mn |
| Sep 30, 2020 | 56.10 Mn |
| Jun 30, 2020 | 57.02 Mn |
| Mar 31, 2020 | 59.95 Mn |
| Dec 31, 2019 | 66.00 Mn |
| Sep 30, 2019 | 64.88 Mn |